Lars Dæhlin Svein Andreas Haukaas

Lars Dæhlin Svein Andreas Haukaas

Auto-generated profile, based on publicly available information

Lars Dæhlin Svein Andreas Haukaas

Department of Surgical Sciences, University of Bergen, Bergen, Norway

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications


6 December 2005 in BJU International
Verified
Journal Article
Open access
PDF file
SHSvein A. Haukaas
Svein A. Haukaas
OHOle J. Halvorsen
Ole J. Halvorsen
LDLars Daehlin
Lars Daehlin
JHJens Hostmark
Jens Hostmark
LALars A. Akslen
Lars A. Akslen
OBJECTIVE: To evaluate the influence of preoperative serum prostate‐specific antigen (PSA) level and other clinicopathological variables on the probability of biochemical failure and clinical recurrence after radical prostatectomy (RP) for localized prostate cancer. PATIENTS AND METHODS: The study was a retrospective survival analysis in 211 patients undergoing retropubic RP for clinically localized prostate cancer in the period 1988–2000. Survival was estimated using the Kaplan‐Meier method; survival endpoints were biochemical failure, defined as a PSA level of ≥ 0.5 ng/mL or clinical recurrence consisting of palpable tumours in the prostatic fossa or distant metastases. In 58 patients with biochemical failure after surgery, we assessed the impact of the doubling time of serum PSA level (PSADT) on the risk of developing skeletal metastases or local recurrence. RESULTS: The median (range) observation period was 66 (9–160) months. Biochemical failure occurred in 92 patients (44%) of whom 39 (42%) had local recurrence or skeletal metastases. There was a highly significant association ( P < 0.001) between clinical T stage, histological grade, capsular penetration, surgical margin status, seminal vesicle invasion, preoperative serum PSA level and the probability of biochemical failure‐free survival. By contrast there was no statistically significant association between preoperative serum PSA level, clinical T stage, surgical margin status, and clinical recurrence. There was a significant relationship between age ( P = 0.021), histological grade ( P = 0.025), capsular penetration ( P = 0.018), seminal vesicle invasion ( P = 0014), and clinical recurrence. Cox regression analysis showed that only histological grade and seminal vesicle invasion were independent predictors of clinical recurrence. In a subgroup of 58 patients with a rising serum PSA level after RP, a PSADT of ≤ 12.8 months conferred a significantly higher risk ( P = 0.015) of developing skeletal metastases than a PSADT of >12.8 months. CONCLUSION: In the present patients undergoing RP the preoperative serum PSA level was not associated with the clinical outcome, whereas it was significantly related to biochemical failure rate. The probability of skeletal metastases was significantly associated with the PSADT after biochemical failure.

20 August 2014 in Scandinavian Journal of Urology
Verified
Journal Article
Closed access
YNYngve Nygård
Yngve Nygård
SHSvein A. Haukaas
Svein A. Haukaas
GEGeir Egil Eide
Geir Egil Eide
OHOle J. Halvorsen
Ole J. Halvorsen
KGKarsten Gravdal
Karsten Gravdal
CBChristian Beisland
Christian Beisland
The aim of this study was to test the ability of prostate cancer antigen-3 (PCA3) and Hansen's PCA3-based nomogram to predict prostate cancer (PCa) probability in a Norwegian cohort, with the goal of reducing unnecessary biopsies. Altogether, 127 consecutive patients were recruited to this study at Haukeland University Hospital, Norway. Prostate-specific antigen (PSA), PCA3 score, digital rectal examination (DRE), prostate volume (Pvol) and age were determined. All patients had an extended 10-core biopsy. The performance of PCA3 score and Hansen's nomogram was tested. There were 124 evaluable patients. Among these, 59 patients had PCa on the initial biopsies. Mean PSA, PCA3 score and age were significantly higher and Pvol was significantly lower in patients with PCa. PCA3 scores of 35 and 21 led to a sensitivity of 71% and 81% and specificity of 72% and 55%, respectively. Hansen's nomogram gave an area under the curve (AUC) of 0.806. The intraclass correlation was 0.959 (Cronbach's alpha). Applied to this material, PCa would be missed in 15.2% of patients when applying the suggested threshold probability of 30%, among whom 66.7% had high-grade PCa. With a threshold probability of 20% only one patient had PCa and this was low grade. Hansen's PCA3-based nomogram is valid for this cohort. A threshold probability of 20% seems more adequate than 30% for this less screened cohort. PCA3 score only affects the biopsy indication in some patients and is recommended only for this subset. The results need to be confirmed in a larger study.

1 January 1999 in Scandinavian Journal of Urology and Nephrology
Verified
Journal Article
Closed access
LHLars Dæhlin Svein Andreas Haukaas
Lars Dæhlin Svein Andreas Haukaas
Conservative treatment with low-fat diet, medium-chain triglyceride or total parenteral nutrition, depending on the general condition of the patient, is the mainstay in the treatment of chylous ascites. In patients with persistent chylous fistula direct surgical closure is a valid treatment option.